Table of Contents Author Guidelines Submit a Manuscript
Mediators of Inflammation
Volume 2017, Article ID 1730245, 16 pages
https://doi.org/10.1155/2017/1730245
Research Article

Evidence for the Involvement of Lipid Rafts and Plasma Membrane Sphingolipid Hydrolases in Pseudomonas aeruginosa Infection of Cystic Fibrosis Bronchial Epithelial Cells

1Dipartimento di Biotecnologie Mediche e Medicina Traslazionale, Università degli Studi di Milano, Milano, Italy
2Laboratorio di Patologia Molecolare-Laboratorio di Chimica Clinica ed Ematologia, Dipartimento di Patologia e Diagnostica, Azienda Ospedaliera Universitaria Integrata di Verona, Ospedale Civile Maggiore, Verona, Italy
3Sezione di Biochimica Clinica, Università degli Studi di Verona, Verona, Italy

Correspondence should be addressed to Nicoletta Loberto; ti.iminu@otrebol.attelocin, Maria Cristina Dechecchi; ti.otenev.rvoa@ihccehced.anitsirc, and Massimo Aureli; ti.iminu@ilerua.omissam

Received 26 April 2017; Revised 2 August 2017; Accepted 30 August 2017; Published 3 December 2017

Academic Editor: Sabine Groesh

Copyright © 2017 Domitilla Schiumarini et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. B. P. O'Sullivan and S. D. Freedman, “Cystic fibrosis,” Lancet, vol. 373, pp. 1891–1904, 2009. View at Publisher · View at Google Scholar · View at Scopus
  2. T. Z. Khan, J. S. Wagener, T. Bost, J. Martinez, F. J. Accurso, and D. W. Riches, “Early pulmonary inflammation in infants with cystic fibrosis,” American Journal of Respiratory and Critical Care Medicine, vol. 151, pp. 1075–1082, 1995. View at Publisher · View at Google Scholar
  3. T. L. Noah, H. R. Black, P. W. Cheng, R. E. Wood, and M. W. Leigh, “Nasal and bronchoalveolar lavage fluid cytokines in early cystic fibrosis,” The Journal of Infectious Diseases, vol. 175, pp. 638–647, 1997. View at Publisher · View at Google Scholar
  4. R. Tirouvanziam, S. de Bentzmann, C. Hubeau et al., “Inflammation and infection in naive human cystic fibrosis airway grafts,” American Journal of Respiratory Cell and Molecular Biology, vol. 23, pp. 121–127, 2000. View at Publisher · View at Google Scholar
  5. J. F. Chmiel, M. Berger, and M. W. Konstan, “The role of inflammation in the pathophysiology of CF lung disease,” Clinical Reviews in Allergy & Immunology, vol. 23, pp. 5–27, 2002. View at Publisher · View at Google Scholar
  6. S. Uhlig and E. Gulbins, “Sphingolipids in the lungs,” American Journal of Respiratory and Critical Care Medicine, vol. 178, pp. 1100–1114, 2008. View at Publisher · View at Google Scholar · View at Scopus
  7. Y. Yang and S. Uhlig, “The role of sphingolipids in respiratory disease,” Therapeutic Advances in Respiratory Disease, vol. 5, pp. 325–344, 2011. View at Publisher · View at Google Scholar · View at Scopus
  8. V. Teichgraber, M. Ulrich, N. Endlich et al., “Ceramide accumulation mediates inflammation, cell death and infection susceptibility in cystic fibrosis,” Nature Medicine, vol. 14, pp. 382–391, 2008. View at Publisher · View at Google Scholar · View at Scopus
  9. C. Guilbault, J. B. De Sanctis, G. Wojewodka et al., “Fenretinide corrects newly found ceramide deficiency in cystic fibrosis,” American Journal of Respiratory Cell and Molecular Biology, vol. 38, pp. 47–56, 2008. View at Publisher · View at Google Scholar · View at Scopus
  10. H. Yu, Y. H. Zeidan, B. X. Wu et al., “Defective acid sphingomyelinase pathway with Pseudomonas aeruginosa infection in cystic fibrosis,” American Journal of Respiratory Cell and Molecular Biology, vol. 41, pp. 367–375, 2009. View at Publisher · View at Google Scholar · View at Scopus
  11. M. Brodlie, M. C. McKean, G. E. Johnson et al., “Raised interleukin-17 is immunolocalised to neutrophils in cystic fibrosis lung disease,” The European Respiratory Journal, vol. 37, pp. 1378–1385, 2011. View at Publisher · View at Google Scholar · View at Scopus
  12. M. Bodas, T. Min, and N. Vij, “Critical role of CFTR-dependent lipid rafts in cigarette smoke-induced lung epithelial injury,” American Journal of Physiology Lung Cellular and Molecular Physiology, vol. 300, pp. L811–L820, 2011. View at Publisher · View at Google Scholar · View at Scopus
  13. L. Nahrlich, J. G. Mainz, C. Adams et al., “Therapy of CF-patients with amitriptyline and placebo - a randomised, double-blind, placebo-controlled phase IIb multicenter, cohort-study,” Cellular Physiology and Biochemistry, vol. 31, pp. 505–512, 2013. View at Publisher · View at Google Scholar · View at Scopus
  14. M. Aureli, D. Schiumarini, N. Loberto et al., “Unravelling the role of sphingolipids in cystic fibrosis lung disease,” Chemistry and Physics of Lipids, vol. 200, pp. 94–103, 2016. View at Publisher · View at Google Scholar · View at Scopus
  15. A. H. Merrill Jr., “Sphingolipid and glycosphingolipid metabolic pathways in the era of sphingolipidomics,” Chemical Reviews, vol. 111, pp. 6387–6422, 2011. View at Publisher · View at Google Scholar · View at Scopus
  16. S. Hakomori, “Bifunctional role of glycosphingolipids. Modulators for transmembrane signaling and mediators for cellular interactions,” The Journal of Biological Chemistry, vol. 265, pp. 18713–18716, 1990. View at Google Scholar
  17. H. J. Kaiser, D. Lingwood, I. Levental et al., “Order of lipid phases in model and plasma membranes,” Proceedings of the National Academy of Sciences of the United States of America, vol. 106, pp. 16645–16650, 2009. View at Publisher · View at Google Scholar · View at Scopus
  18. S. Sonnino, M. Aureli, L. Mauri, M. G. Ciampa, and A. Prinetti, “Membrane lipid domains in the nervous system,” Frontiers in Bioscience, vol. 20, pp. 280–302, 2015. View at Publisher · View at Google Scholar · View at Scopus
  19. K. Simons and J. L. Sampaio, “Membrane organization and lipid rafts,” Cold Spring Harbor Perspectives in Biology, vol. 3, article a004697, 2011. View at Publisher · View at Google Scholar · View at Scopus
  20. K. Kabayama, T. Sato, K. Saito et al., “Dissociation of the insulin receptor and caveolin-1 complex by ganglioside GM3 in the state of insulin resistance,” Proceedings of the National Academy of Sciences of the United States of America, vol. 104, pp. 13678–13683, 2007. View at Publisher · View at Google Scholar · View at Scopus
  21. A. Prinetti, N. Loberto, V. Chigorno, and S. Sonnino, “Glycosphingolipid behaviour in complex membranes,” Biochimica et Biophysica Acta (BBA) - Biomembranes, vol. 1788, pp. 184–193, 2009. View at Publisher · View at Google Scholar · View at Scopus
  22. G. van Meer, D. R. Voelker, and G. W. Feigenson, “Membrane lipids: where they are and how they behave,” Nature Reviews. Molecular Cell Biology, vol. 9, pp. 112–124, 2008. View at Publisher · View at Google Scholar · View at Scopus
  23. M. Aureli, N. Loberto, V. Chigorno, A. Prinetti, and S. Sonnino, “Remodeling of sphingolipids by plasma membrane associated enzymes,” Neurochemical Research, vol. 36, pp. 1636–1644, 2011. View at Publisher · View at Google Scholar · View at Scopus
  24. A. Magini, A. Polchi, L. Urbanelli et al., “TFEB activation promotes the recruitment of lysosomal glycohydrolases β-hexosaminidase and β-galactosidase to the plasma membrane,” Biochemical and Biophysical Research Communications, vol. 440, pp. 251–257, 2013. View at Publisher · View at Google Scholar · View at Scopus
  25. N. Loberto, M. Tebon, I. Lampronti et al., “GBA2-encoded β-glucosidase activity is involved in the inflammatory response to Pseudomonas aeruginosa,” PLoS One, vol. 9, article e104763, 2014. View at Publisher · View at Google Scholar · View at Scopus
  26. K. A. Becker, J. Riethmuller, A. Luth, G. Döring, B. Kleuser, and E. Gulbins, “Acid sphingomyelinase inhibitors normalize pulmonary ceramide and inflammation in cystic fibrosis,” American Journal of Respiratory Cell and Molecular Biology, vol. 42, pp. 716–724, 2010. View at Publisher · View at Google Scholar · View at Scopus
  27. J. Zabner, P. Karp, M. Seiler et al., “Development of cystic fibrosis and noncystic fibrosis airway cell lines,” American Journal of Physiology Lung Cellular and Molecular Physiology, vol. 284, pp. L844–L854, 2003. View at Publisher · View at Google Scholar
  28. M. Aureli, R. Bassi, N. Loberto et al., “Cell surface associated glycohydrolases in normal and Gaucher disease fibroblasts,” Journal of Inherited Metabolic Disease, vol. 35, pp. 1081–1091, 2012. View at Publisher · View at Google Scholar · View at Scopus
  29. M. C. Dechecchi, E. Nicolis, V. Bezzerri et al., “MPB-07 reduces the inflammatory response to Pseudomonas aeruginosa in cystic fibrosis bronchial cells,” American Journal of Respiratory Cell and Molecular Biology, vol. 36, pp. 615–624, 2007. View at Publisher · View at Google Scholar · View at Scopus
  30. M. C. Dechecchi, E. Nicolis, C. Norez et al., “Anti-inflammatory effect of miglustat in bronchial epithelial cells,” Journal of Cystic Fibrosis, vol. 7, pp. 555–565, 2008. View at Publisher · View at Google Scholar · View at Scopus
  31. N. Loberto, S. Prioni, A. Bettiga, V. Chigorno, A. Prinetti, and S. Sonnino, “The membrane environment of endogenous cellular prion protein in primary rat cerebellar neurons,” Journal of Neurochemistry, vol. 95, pp. 771–783, 2005. View at Publisher · View at Google Scholar · View at Scopus
  32. M. Aureli, S. Prioni, L. Mauri et al., “Photoactivable sphingosine as a tool to study membrane microenvironments in cultured cells,” Journal of Lipid Research, vol. 51, pp. 798–808, 2010. View at Publisher · View at Google Scholar · View at Scopus
  33. F. Scandroglio, J. K. Venkata, N. Loberto et al., “Lipid content of brain, brain membrane lipid domains, and neurons from acid sphingomyelinase deficient mice,” Journal of Neurochemistry, vol. 107, pp. 329–338, 2008. View at Publisher · View at Google Scholar · View at Scopus
  34. M. Aureli, N. Loberto, P. Lanteri, V. Chigorno, A. Prinetti, and S. Sonnino, “Cell surface sphingolipid glycohydrolases in neuronal differentiation and aging in culture,” Journal of Neurochemistry, vol. 116, pp. 891–899, 2011. View at Publisher · View at Google Scholar · View at Scopus
  35. M. Aureli, A. P. Masilamani, G. Illuzzi et al., “Activity of plasma membrane β-galactosidase and β-glucosidase,” FEBS Letters, vol. 583, pp. 2469–2473, 2009. View at Publisher · View at Google Scholar · View at Scopus
  36. H. S. Overkleeft, G. H. Renkema, J. Neele et al., “Generation of specific deoxynojirimycin-type inhibitors of the non-lysosomal glucosylceramidase,” The Journal of Biological Chemistry, vol. 273, pp. 26522–26527, 1998. View at Google Scholar
  37. M. Aureli, A. Gritti, R. Bassi et al., “Plasma membrane-associated glycohydrolases along differentiation of murine neural stem cells,” Neurochemical Research, vol. 37, pp. 1344–1354, 2012. View at Publisher · View at Google Scholar · View at Scopus
  38. R. Gatti, C. Lombardo, M. Filocamo, C. Borrone, and E. Porro, “Comparative study of 15 lysosomal enzymes in chorionic villi and cultured amniotic fluid cells. Early prenatal diagnosis in seven pregnancies at risk for lysosomal storage diseases,” Prenatal Diagnosis, vol. 5, pp. 329–336, 1985. View at Publisher · View at Google Scholar · View at Scopus
  39. S. C. Sorli, S. Colie, V. Albinet et al., “The nonlysosomal β-glucosidase GBA2 promotes endoplasmic reticulum stress and impairs tumorigenicity of human melanoma cells,” The FASEB Journal, vol. 27, pp. 489–498, 2013. View at Publisher · View at Google Scholar · View at Scopus
  40. H. Grassme, A. Cremesti, R. Kolesnick, and E. Gulbins, “Ceramide-mediated clustering is required for CD95-DISC formation,” Oncogene, vol. 22, pp. 5457–5470, 2003. View at Publisher · View at Google Scholar · View at Scopus
  41. Y. Itokazu, R. E. Pagano, A. S. Schroeder, S. M. O'Grady, A. H. Limper, and D. L. Marks, “Reduced GM1 ganglioside in CFTR-deficient human airway cells results in decreased β1-integrin signaling and delayed wound repair,” American Journal of Physiology Cell Physiology, vol. 306, pp. C819–C830, 2014. View at Publisher · View at Google Scholar · View at Scopus
  42. H. Grassme, V. Jendrossek, A. Riehle et al., “Host defense against Pseudomonas aeruginosa requires ceramide-rich membrane rafts,” Nature Medicine, vol. 9, pp. 322–330, 2003. View at Publisher · View at Google Scholar · View at Scopus
  43. R. Valaperta, V. Chigorno, L. Basso et al., “Plasma membrane production of ceramide from ganglioside GM3 in human fibroblasts,” The FASEB Journal, vol. 20, pp. 1227–1229, 2006. View at Publisher · View at Google Scholar · View at Scopus
  44. M. Aureli, R. Bassi, A. Prinetti et al., “Ionizing radiations increase the activity of the cell surface glycohydrolases and the plasma membrane ceramide content,” Glycoconjugate Journal, vol. 29, no. 8-9, pp. 585–597, 2012. View at Publisher · View at Google Scholar · View at Scopus